Article
A novel model associated with tumor microenvironment on predicting prognosis and immunotherapy in Triple Negative Breast Cancer
2023-04-03
Abstract excerpt
<h4>Background: </h4> TNBC (Triple Negative Breast Cancer) is the most aggressive and malignant subtype in breast cancer. Immunotherapy is a currently promising and effective treatment for TNBC, while not all patients are responsive. Therefore, it is necessary to explore novel biomarkers to screen sensitive populations for immunotherapy. Methods All mRNA expression profiles of TNBC from The Cancer Genome Atlas (T...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ea9cfdaa-ed5d-54a7-8901-273f339266d9
- DOI
- 10.21203/rs.3.rs-2730381/v1
